The accumulative mortality rate in the BRL group was significantly higher than that in the non-BRL group (p<0.05, 32% vs. 12%), and these results suggested that β3-AR agonist (BRL37344) might be associated with an increased risk of death in aged rats with heart failure. This evidence concerns the gene ADRB3 and heart failure.